Southern States of India are attracting majority of biotech investments and enterprises. Of the eight biotech SEZs that have either received formal or in-principle approvals from the Board of Approvals (BoA) on SEZs across the country, seven are from the four Southern States of India.

This is in addition to many biotech companies already operating in the four states. These developments besides bringing huge investments in the region are also to generate significant employment opportunities in the field. Karnataka and Andhra Pradesh are becoming preferred destinations for biotech investments.

Biocon has earlier obtained formal approval to set up a biotech SEZ in Bangalore in 36 hectares. Jubilant Organosys has received an in-principle approval for a BT SEZ in Mysore in about 11 hectares. Karnataka Biotechnology and Information Technology Services (KBITS) also obtained a formal approval to establish a Biotech SEZ in Bangalore in an area of 43 hectares.

Parsvanath Developers also obtained in-principle nod to set up a bio-pharma SEZ at Tattanaram Village in Ranga Reddy District of Andhra Pradesh in 10.11 hectares. The Andhra Pradesh Industrial Infrastructure Corporation (APIIC) also obtained a formal approval for a Biotech SEZ in Medak District of Andhra Pradesh in an area of 40.47 hectares.

Biopure Healthcare is planning to set up a Biopharmaceuticals SEZ at Hosur, Krishnagiri District of Tamil Nadu in 365 hectares for which it obtained an in-principle nod early October 2006. A formal approval has been given to TCG Urban Infrastructure Holdings Limited for a Biotechnology SEZ in Cochin, Kerala in 12 hectares.

Maharashtra Industrial Development Corporation (MIDC) has been approved to establish a Biotech SEZ at Jalna in Maharashtra in 40.33 hectares.